{
    "nctId": "NCT02037269",
    "briefTitle": "LightPathTM Imaging System for Ex-vivo Assessment of Margin and Lymph Node Status in Breast Cancer Surgical Specimens",
    "officialTitle": "A Pilot Study to Evaluate Cerenkov Luminescence Imaging for Measuring Margin and Lymph Node Status in Breast Cancer Surgical Specimens",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 25,
    "primaryOutcomeMeasure": "Tumour margin status of the Wide Local Excision specimen as determined by the LightPathTM Imaging System",
    "eligibilityCriteria": "Inclusion Criteria\n\n* Females \u226530 years of age with a diagnosis of invasive breast cancer or DCIS\n* Scheduled for BCS +/- SLNB or ALND\n* Females of childbearing age must have a negative pregnancy test (by Beta HCG qualitative analysis), must have had a history of a surgical sterilisation, or must give history of no menses in past twelve months\n\nExclusion Criteria\n\n* Surgery or radiotherapy in the operated breast in the past 2 years\n* Neoadjuvant systemic therapy\n* Patients not suitable for BCS\n* Blood glucose level \u2265 12 mmol/l on the day of surgery\n* Known hypersensitivity to 18F-FDG\n* Any patient who is pregnant or lactating",
    "sex": "FEMALE",
    "minimumAge": "30 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}